Weil advised Blue Star Innovation Partners, a growth-focused investment firm that partners with leading software and payments companies, in its partnership agreement with Ledger Run, a leading provider of technology services that optimize workflows in the clinical trials space.
Ledger Run has established itself as a leading innovator in the contract-to-pay solution for clinical trials. The injection of capital coupled with Blue Star’s operational, software, and integrated payments expertise will help to further accelerate new product releases and maintain the company’s high level of customer service.
The Weil team was led by Private Equity partner David Gail and included Private Equity associates Patrick Hosch, Spencer Finney and Hunter Zepeda; Executive Compensation & Benefits partner Jennifer Britz and associate Amanda Nowak; Employment partner Rebecca Sivitz and associate Paige Mickel; Technology & IP Transactions partner Dennis Adams, counsel Catherine Kim and associate Aron Lichtschein; U.S. Privacy & Cybersecurity Head Olivia Greer and associate David Merck; Tax partner Jason Vollbracht and associate Charles Kogel; Regulatory Transactions partner Timothy Welch and counsel Ariel Fliman; Antitrust counsel Carla Hine; and Private Funds counsel Jessica Lurie and associate Cassandra Xia.
